Charlottesville Angel Network

Overview

Charlottesville Angel Network (CAN) is an angel investment group based in Charlottesville, Virginia, dedicated to supporting early-stage companies with high-growth potential. The network comprises over 70 accredited investors and family offices who make independent investment decisions. CAN has invested more than $20 million in nearly 80 startups, fostering innovation both locally and beyond. CAN primarily invests in seed, angel, and friends & family rounds up through Series A in promising startups raising less than $5 million. The typical investment size ranges from $100,000 to $300,000 per round, often partnering with co-investors. While CAN has a particular affinity for Virginia-based companies, over half of its investments are in-state; it remains open to promising startups nationwide. The network's portfolio includes sectors such as SaaS, digital healthcare, biotech, aerospace, consumer products, clean energy, food and beverages, and more. Over the past decade, CAN has not only provided capital but also mentorship and strategic guidance to startups, contributing to the growth of a vibrant entrepreneurial ecosystem in Charlottesville and beyond. Notable successes include Palvella Therapeutics, which merged with Pieris Pharmaceuticals in December 2024, and Dive Technologies, acquired by Anduril Industries in February 2022. These exits underscore CAN's ability to identify and nurture high-potential startups, setting a precedent for future investments.

Investment Focus

• Accredited Investor Status

Portfolio Companies